Low dose quetiapine induced galactorrhoea: A case report

Clinical Practice and Epidemiology in Mental Health

Volumn 3, Issue , 2007, Pages

  Gupta, Maneesh ^a  

^a Research Team   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GABAPENTIN; PROCYCLIDINE; PROLACTIN; QUETIAPINE; VALPROATE SEMISODIUM; VENLAFAXINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DROWSINESS; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; GALACTORRHEA; HUMAN; LOW DRUG DOSE; MUSCLE SPASM; PERSONALITY DISORDER; PROLACTIN BLOOD LEVEL;

EID: 34548593412     PISSN: 17450179     EISSN: None     Source Type: Journal    
DOI: 10.1186/1745-0179-3-12     Document Type: Article

References (14)

1. Haddad PM, Wieck A: Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 2004, 4(20):2291-314. 10.2165/00003495-200464200-00003
2. Goodnick PI, Rodriguez L, Santana O: Antipsychotics: impact on prolactin levels, Expert Opin Pharmacother 2002, 3(10):1381-91. 10.1517/ 14656566.3.10.1381 12387684
3. Atmaca M, Kuloglu M, Tezcan E, Canatan H, Gecici O: Quetiapine is not associated with increase in prolactin secretion in contrast to haloperidol, Arch Med Res 2002, 33(6):562-5. 10.1016/ S0188-4409(02)00403-4 12505103
4. Dickson RA, Seeman MV, Corenblum B: Hormonal side effects in women: typical versus atypical antipsychotic treatment, J Clin Psychiatry 2000, 61(Suppl 3):10-15. 10724128
5. Keller R, Mongini F: Switch to Quetiapine in antipsychotic agent-related hyperprolactinemia, Neurol Sci 2002, 23:233-35. 10.1007/s100720200047 12522680
6. Kingsbury J Steven, Castelo Catherine, Abulseoud Osama: Quetiapine for olanzapine-induced galactorrhea, The American Journal of Psychiatry 2002, 159(6):1061. 10.1176/appi.ajp.159.6.1061 12042203
7. Wirshing DA, Erhart SM, Pierre JM, Boyd JA: Nonextrapyramidal side effects of novel antipsychotics. Curr Opin Psychiatry 2000. 13:45-50. 10.1097/00001504-200001000-00008
8. Lambert M, Haro JM, Novick D, Edgell ET, Kennedy L, Ratcliffe M, Naber D: Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study, Acta Psychiatr Scand 2005, 111(3):232-43. 10.1111/j.1600-0447.2004.00451.x 15701108
9. Ataya KM, Subramanian MG, Lawson DM, Gala RR, Euprolactinemic Galactorrhoea: Response of bioassayable prolactin to thyrotropin-releasing hormone, J Reprod Med 1996, 41:156-160. 8778412
10. Pae CU, Kim JJ, Lee CU, Chae JH, Lee SJ, Lee C, Paik IH: Very low dose quetiapine-induced galactorrhea in combination with venlafaxine, Hum Psychopharmacol 2004, 19(6):433-4. 10.1002/hup.606 15303249
11. Kapur S, Zipursky R, Jones C, Shammi CS, Remington G, Seeman P: A Positron Emission Tomography Study of Quetiapine in Schizophrenia, Arch Gen Psy 2000, 57:533-559. 10.1001/archpsyc.57.6.533
12. Kapur S, Langlois X, Vinken P, Megens AAHP, De Coster R, Andrews JS: The Differential Effects of Atypical Antipsychotics on Prolactin Elevation Are Explained by Their Differential Blood-Brain Disposition: A Pharmacological Analysis in Rats, The Journal of Pharmacology and Experimental Therapeutics 2002, 302:1129-1134. 10.1124/jpet.102.035303
13. Alexiadis M, Whitehorn D, Woodley H, Kopala L: Prolactin Elevation with Quetiapine, Am J Psy 2002, 159(9)1608-9. 10.1176/appi.ajp.159.9.1608
14. Buhagiar K, Cassar JR: Quetiapine-Induced Hyperprolactinemic Galactorrhoea in an Adolescent Male, German J Psych 2006, 9:118-120. http://www.gjpsy.uni-goettingen.de/gjp-article-buhagiar.pdf